SE425392B - Forfarande for framstellning av nya 5,9-beta-disubstituerade 2-tetrahydrofurfuryl-6,7-bensomorfaner eller deras syraadditionssalter - Google Patents

Forfarande for framstellning av nya 5,9-beta-disubstituerade 2-tetrahydrofurfuryl-6,7-bensomorfaner eller deras syraadditionssalter

Info

Publication number
SE425392B
SE425392B SE7508789A SE7508789A SE425392B SE 425392 B SE425392 B SE 425392B SE 7508789 A SE7508789 A SE 7508789A SE 7508789 A SE7508789 A SE 7508789A SE 425392 B SE425392 B SE 425392B
Authority
SE
Sweden
Prior art keywords
benzomorphanes
tetrahydrofurfuryl
disubstituted
beta
procedure
Prior art date
Application number
SE7508789A
Other languages
English (en)
Swedish (sv)
Other versions
SE7508789L (sv
Inventor
H Merz
A Langbein
G Walther
K Stockhaus
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of SE7508789L publication Critical patent/SE7508789L/
Publication of SE425392B publication Critical patent/SE425392B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE7508789A 1974-08-05 1975-08-04 Forfarande for framstellning av nya 5,9-beta-disubstituerade 2-tetrahydrofurfuryl-6,7-bensomorfaner eller deras syraadditionssalter SE425392B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2437610A DE2437610A1 (de) 1974-08-05 1974-08-05 Neue 5,9-beta-disubstituierte 2-tetrahydrofurfuryl-6,7-benzomorphane, deren saeureadditionssalze, ihre verwendung als arzneimittel und verfahren zu deren herstellung

Publications (2)

Publication Number Publication Date
SE7508789L SE7508789L (sv) 1976-02-10
SE425392B true SE425392B (sv) 1982-09-27

Family

ID=5922448

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7508789A SE425392B (sv) 1974-08-05 1975-08-04 Forfarande for framstellning av nya 5,9-beta-disubstituerade 2-tetrahydrofurfuryl-6,7-bensomorfaner eller deras syraadditionssalter

Country Status (27)

Country Link
US (1) US3982005A (en16)
JP (1) JPS60358B2 (en16)
AT (1) AT348140B (en16)
BE (1) BE832099R (en16)
BG (3) BG25088A3 (en16)
CA (1) CA1049008A (en16)
CH (7) CH613963A5 (en16)
CS (1) CS189717B2 (en16)
DD (1) DD122685A5 (en16)
DE (1) DE2437610A1 (en16)
DK (1) DK138992C (en16)
ES (6) ES452766A1 (en16)
FI (1) FI63229C (en16)
FR (1) FR2320096A2 (en16)
GB (1) GB1513950A (en16)
HU (1) HU177952B (en16)
IE (1) IE42216B1 (en16)
IL (1) IL47860A (en16)
LU (1) LU73138A1 (en16)
NL (1) NL7509249A (en16)
NO (1) NO143460C (en16)
PH (1) PH13687A (en16)
PL (3) PL99816B1 (en16)
RO (3) RO67390A (en16)
SE (1) SE425392B (en16)
SU (3) SU591147A3 (en16)
ZA (1) ZA754997B (en16)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4087532A (en) * 1974-03-09 1978-05-02 Boehringer Ingelheim Gmbh Analgesically useful 2-tetrahydrofurfuryl-5-lower alkyl-2-oxy-6,7-benzomorphans and salts thereof
GB1575009A (en) * 1976-06-21 1980-09-17 Acf Chemiefarma Nv 6,7-benzomorphan derivatives
DE2716687A1 (de) * 1977-04-15 1978-10-19 Boehringer Sohn Ingelheim 2'-hydroxy-2-(5-isoxazolylmethyl)-6,7benzomorphane, deren saeureadditionssalze und diese enthaltende arzneimittel
NL7804509A (nl) * 1978-04-26 1979-10-30 Acf Chemiefarma Nv Nieuwe 6,7-benzomorfanderivaten en zuuradditiezouten daarvan.
DE2828039A1 (de) * 1978-06-26 1980-01-10 Boehringer Sohn Ingelheim 2-(2-alkoxyethyl)-2'-hydroxy-6,7-benzomorphane deren saeureadditionssalze diese enthaltende arzneimittel und verfahren zu deren herstellung
JPS5636521A (en) * 1979-08-31 1981-04-09 Shin Etsu Chem Co Ltd Production of alkenyloxy group-containing organopolysiloxane
TW200911796A (en) 2007-07-26 2009-03-16 Vitae Pharmaceuticals Inc Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1
EP2220048B1 (en) 2007-11-16 2017-01-25 Boehringer Ingelheim International GmbH Aryl- and heteroarylcarbonyl derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
CA2708303A1 (en) 2007-12-11 2009-06-18 Vitae Pharmaceuticals, Inc. Cyclic urea inhibitors of 11.beta.-hydroxysteroid dehydrogenase 1
TW200934490A (en) 2008-01-07 2009-08-16 Vitae Pharmaceuticals Inc Lactam inhibitors of 11 &abgr;-hydroxysteroid dehydrogenase 1
WO2009094169A1 (en) 2008-01-24 2009-07-30 Vitae Pharmaceuticals, Inc. Cyclic carbazate and semicarbazide inhibitors of 11beta-hydroxysteroid dehydrogenase 1
EP2254872A2 (en) 2008-02-15 2010-12-01 Vitae Pharmaceuticals, Inc. Cycloalkyl lactame derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
CA2723034A1 (en) 2008-05-01 2009-11-05 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
CL2009001059A1 (es) 2008-05-01 2010-11-12 Boehringer Ingelheim Int Compuestos derivados de 1,3-oxazin-2-ona-3,6 sustituidos, inhibidores de la actividad de la 11-beta-hidroxiesteroide deshidrogenasa i; composicion farmaceutica que los comprende; utiles en el tratamiento de enfermedades tales como diabetes mellitus, entre otras.
US8569292B2 (en) 2008-05-01 2013-10-29 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1
JP5711115B2 (ja) 2008-05-13 2015-04-30 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ベンゾモルファン及び関連骨格のアリサイクリックカルボン酸誘導体、そのような化合物を含有する医薬及びその使用
ES2432150T3 (es) 2008-07-25 2013-12-02 Boehringer Ingelheim International Gmbh Inhibidores cíclicos de la 11 beta-hidroxiesteroide deshidrogenasa 1
US8846668B2 (en) 2008-07-25 2014-09-30 Vitae Pharmaceuticals, Inc. Inhibitors of 11beta-hydroxysteroid dehydrogenase 1
US8680093B2 (en) 2009-04-30 2014-03-25 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
WO2011011123A1 (en) 2009-06-11 2011-01-27 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 based on the 1,3 -oxazinan- 2 -one structure
AR078887A1 (es) 2009-11-06 2011-12-07 Boehringer Ingelheim Int Derivados arilo y heteroarilcarbonilo de hexahidroindenopiridina y octahidrobenzoquinolina y composiciones farmaceuticas que los contienen.
WO2011159760A1 (en) 2010-06-16 2011-12-22 Vitae Pharmaceuticals, Inc. Substituted 5-,6- and 7-membered heterocycles, medicaments containing such compounds, and their use
TWI537258B (zh) 2010-11-05 2016-06-11 百靈佳殷格翰國際股份有限公司 六氫茚并吡啶及八氫苯并喹啉之芳基－及雜環芳基羰基衍生物
JP2014524438A (ja) 2011-08-17 2014-09-22 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング インデノピリジン誘導体
JP7574861B2 (ja) 2020-11-26 2024-10-29 信越化学工業株式会社 室温硬化性オルガノポリシロキサン組成物及び物品並びに加水分解性オルガノシラン化合物及びその製造方法
CN117881724A (zh) 2021-09-03 2024-04-12 信越化学工业株式会社 有机聚硅氧烷化合物、室温固化性有机聚硅氧烷组合物和物品

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE582575A (en16) * 1958-09-22
US3700734A (en) * 1969-01-23 1972-10-24 Merck & Co Inc 2{40 -hydroxy-2,3,5-trimethyl-6,7-benzomorphan
DE2105743C3 (de) * 1971-02-08 1979-11-29 Boehringer Sohn Ingelheim 2-(Furylmethyl)- a -5,9-dialkyl -6,7benzomorphane, Verfahren zu ihrer Herstellung und deren Verwendung
CS166803B2 (en16) * 1971-02-08 1976-03-29 Boehringer Sohn Ingelheim
DE2200596A1 (de) * 1972-01-07 1973-07-12 Boehringer Sohn Ingelheim N-(furyl-methyl)-2'-hydroxy-5-phenyl6,7-benzomorphane, deren saeureadditionssalze sowie verfahren zu deren herstellung
DE2217420C3 (de) * 1972-04-12 1981-03-12 C.H. Boehringer Sohn, 6507 Ingelheim N-Thienylmethyl-Heterocyclen, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zubereitungen
DE2229695A1 (de) * 1972-06-19 1974-01-31 Boehringer Sohn Ingelheim 2-(heteroaryl-methyl)-5,9 beta-dialkyl6,7-benzomorphane, deren saeureadditionssalze sowie verfahren zu deren herstellung

Also Published As

Publication number Publication date
GB1513950A (en) 1978-06-14
DK138992C (da) 1979-04-30
ES452763A1 (es) 1977-10-01
FI752211A7 (en16) 1976-02-06
BE832099R (fr) 1976-02-04
ZA754997B (en) 1977-04-27
JPS60358B2 (ja) 1985-01-07
BG25090A3 (bg) 1978-07-12
CH615679A5 (en16) 1980-02-15
RO72736A (ro) 1982-09-09
CH615680A5 (en16) 1980-02-15
ES452765A1 (es) 1977-10-16
IL47860A0 (en) 1975-11-25
DE2437610A1 (de) 1976-02-26
CS189717B2 (en) 1979-04-30
SU587859A3 (ru) 1978-01-05
SE7508789L (sv) 1976-02-10
DK138992B (da) 1978-11-27
ES452764A1 (es) 1977-10-16
CH616420A5 (en16) 1980-03-31
CH615678A5 (en16) 1980-02-15
AT348140B (de) 1979-01-25
IL47860A (en) 1979-01-31
CH615677A5 (en16) 1980-02-15
PL99838B1 (pl) 1978-08-31
PH13687A (en) 1980-09-01
RO67390A (ro) 1981-06-30
CH616421A5 (en16) 1980-03-31
DK352875A (da) 1976-02-06
NO143460B (no) 1980-11-10
NO752731L (en16) 1976-02-06
FR2320096B2 (en16) 1978-09-01
HU177952B (en) 1982-02-28
ES452767A1 (es) 1977-10-01
IE42216L (en) 1976-02-05
RO72735A (ro) 1982-09-09
FI63229C (fi) 1983-05-10
SU587858A3 (ru) 1978-01-05
IE42216B1 (en) 1980-07-02
CH613963A5 (en16) 1979-10-31
FI63229B (fi) 1983-01-31
BG25089A3 (bg) 1978-07-12
ES452768A1 (es) 1977-10-01
SU591147A3 (ru) 1978-01-30
NO143460C (no) 1981-02-18
NL7509249A (nl) 1976-02-09
ES452766A1 (es) 1977-10-01
PL99819B1 (pl) 1978-08-31
LU73138A1 (en16) 1977-04-13
BG25088A3 (bg) 1978-07-12
JPS5139673A (en) 1976-04-02
DD122685A5 (en16) 1976-10-20
AU8364675A (en) 1977-02-10
PL99816B1 (pl) 1978-08-31
US3982005A (en) 1976-09-21
ATA523775A (de) 1978-06-15
CA1049008A (en) 1979-02-20
FR2320096A2 (fr) 1977-03-04

Similar Documents

Publication Publication Date Title
SE425392B (sv) Forfarande for framstellning av nya 5,9-beta-disubstituerade 2-tetrahydrofurfuryl-6,7-bensomorfaner eller deras syraadditionssalter
DK140430B (da) Analogifremgangsmåde til fremstilling af 3-aryloxy-3-phenylpropylaminer eller syreadditionssalte heraf.
DK137188C (da) Analogifremgangsmaade til fremstilling af 2-tetrahydrofurfuryl-6,7-benzomorphaner eller syreadditionssalte heraf
SE426828B (sv) Nytt forfarande for framstellning av 7beta-acylamino-7alfa-alkoxicefalosporiner eller 6beta-acylamino-6alfa-alkoxipenicilliner
NO140427C (no) Fremgangsmaate til fremstilling av antibiotikum 1-n-(l-(-)-alfa-hydroksy-gamma-aminobutyryl)-xk-62-2 eller syreaddisjonssalter derav
DK441875A (da) Fremgangsmade til fremstilling af 2-phenyliminoimidazolidiner eller syreadditionssalte deraf
NO153299C (no) Fremgangsmaate for fremstilling av 6-d-alfa-amino-alfa-(p-hydroksy-fenyl)-acetamido-penicillansyre eller salter derav.
SE418085B (sv) Forfarande for framstellning av nya sulfamoylbensoesyraamider
DK131778C (da) Fremgangsmade til fremstilling af substituerede 3-hydroksymetylisokinolinderivater eller syreadditionssalte heraf
SE402009B (sv) Forfarande for framstellning av 9-desoxi-prosta-5,9,(10),13-triensyraderivat
DK137606C (da) Analogifremgangsmaade til fremstilling af substituerede 2-phenylamino-imidazoliner-(2) eller syreadditionssalte deraf
DK137953B (da) Analogifremgangsmåde til fremstilling af amidoximderivater eller syreadditionssalte deraf.
DK139574B (da) Analogifremgangsmåde til fremstilling af terpeno-phenoxy-alkylaminer eller syreadditionssalte deraf.
DK131857C (da) Analogifremgangsmade til fremstilling af 4-hydroxymethyl-1-phthalazonderivater eller syreadditionssalte deraf
NO142627C (no) Fremgangsmaate for fremstilling av poly-alfa-hydroksyakrylsyrer eller av kopolymerer av poly-alfa-hydroksyakrylsyre
SE431216B (sv) Forfarande for framstellning av 1n-(alfa-hydroxi-omega-amino-alkanoyl)-6 721n-metyl-3 721, 4 721-dideoxikanamycin b eller farmaceutiskt godtagbara syraadditionssalter derav
DK138266B (da) Analogifremgangsmåde til fremstilling af basiske derivater af 1-aryl-2-oxo-2,4,5,6,7,7a-hexahydroindoler eller syreadditionssalte deraf.
DK128779B (da) Analogifremgangsmåde til fremstilling af 2-arylamino-imidazolin-(2)'er eller syreadditionssalte deraf.
DK134436C (da) Analogifremgangsmade til fremstilling af s(iv)-benzo-1,2,4-thiadiaziner eller syreadditionssalte deraf
DK132324C (da) Analogifremgangsmade til fremstilling af dibenzo(d,f)(1,3)dioxepiner eller alkalimetalsalte eller syreadditionssalte deraf
SE427181B (sv) Forfarande for framstellning av nya n-substituerade 6,7-bensomorfaner
DK137796B (da) Fremgangsmåde til fremstilling af 1-aryloxy-3-aminopropanolderivater eller syreadditionssalte deraf.
DK134752C (da) Analogifremgangsmade til fremstilling af(+)-3r-n-monomethyl-amino-4c-phenyl-4t-ethoxycarbonyl-cyclohexen-(1)eller syreadditionssalte deraf
SE7506576L (sv) Forfarande for framstellning av 3-metyl-4-fenyl-3-butensyra.
DK143559C (da) Analogifremgangsmaade til fremstilling af 5'-heptamethylenimino-pentyl-xanthen-9-carboxylat eller syreadditionssalte deraf

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7508789-0

Effective date: 19890911

Format of ref document f/p: F